• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Advanced Life Sciences Holdings

edit

Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of drugs in the areas of infectious disease, oncology and respiratory disease. The Company has assembled a pipeline of clinical and preclinical product candidates. The Company has a worldwide license (excluding Japan) from Abbott Laboratories (Abbott) to develop and commercialize cethromycin, once-a-day antibiotic for the treatment of respiratory tract infections.

Recent Milestones

edit

• 
  Advanced Life Sciences Holdings — Advanced Life Sciences Receives $1.5 Million From Exercise of Unit Warrants and Secures Financing Commitment (9/28/10)
  Posted 10/31/10 at 8:21pm via corporate-ir.net
• 
  Advanced Life Sciences Holdings added Michael T. Flavin as CEO & Chairman.
  Posted 10/31/10 at 8:21pm
• 
  Advanced Life Sciences Holdings added John L. Flavin as President, CFO and Director.
  Posted 10/31/10 at 8:21pm

Videos

Screenshots

edit

Sources

Advanced Life Sciences Receives $1.5 Million From Exercise of Unit Warrants and Secures Financing Commitment (phx.corporate-ir.net) [edit]